Sciclone Pharma (SCLN) Reports Q1 EPS of $0.19

May 10, 2016 6:25 AM EDT

Sciclone Pharma (NASDAQ: SCLN) reported Q1 EPS of $0.19, versus $0.19 reported last year. Revenue for the quarter came in at $36.5 million, versus $33.6 million reported last year.

For earnings history and earnings-related data on Sciclone Pharma (SCLN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings